Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03792659 · ClinicalTrials.gov registry record
The EXPLORE MG Registry for Myasthenia Gravis
A clinical trial of Myasthenia Gravis, sponsored by Yale University.
- Recruiting
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT03792659 is a study of Myasthenia Gravis that is actively recruiting participants, run by Yale University. The registered enrollment target is 800 participants, above the 166-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (382% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03792659, a study of Myasthenia Gravis, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.
Conditions Studied
Interventions
- OTHER Blood Sample Draw
Study Locations (1)
Connecticut
- Yale-New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2016-03-30 |
| Est. Completion | 2026-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03792659
The ClinicalTrials.gov registry entry for NCT03792659 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 166-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (382% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myasthenia Gravis appearing as the primary indexed condition, and to 1 intervention - of which Blood Sample Draw is the first listed.
NCT03792659 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT03792659 about?
NCT03792659 is a clinical study titled "The EXPLORE MG Registry for Myasthenia Gravis". The purpose of this study is to create a Yale University Department of Neurology Myasthenia Gravis (MG) registry that will be used for current and future research projects involving the study of Myasthenia Gravis.
What is the current status of trial NCT03792659?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2016-03-30. Estimated completion is 2026-10-30.
What conditions does trial NCT03792659 study?
This clinical trial studies the following conditions: Myasthenia Gravis.
What interventions are being tested in trial NCT03792659?
The interventions under investigation include: Blood Sample Draw (OTHER).
Who is sponsoring clinical trial NCT03792659?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03792659 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RECRUITING
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RECRUITING · Phase 3
-
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RECRUITING
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.